{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:48Z","timestamp":1787181888480,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010725","name":"An-Najah National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119732","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:12:51Z","timestamp":1784261571000},"page":"119732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TGR5 activation impairs lung natural killer cell function and promotes bile acid\u2013mediated injury in metabolic liver disease"],"prefix":"10.1016","volume":"202","author":[{"given":"Alaa Mohammed","family":"Felel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8843-1612","authenticated-orcid":false,"given":"Hanin","family":"Takhman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Salhab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2026.119732_bib1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119732_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000324126","article-title":"The bile acid membrane receptor TGR5: a valuable metabolic target","volume":"29","author":"Pols","year":"2011","journal-title":"Dig. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2026.119732_bib3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"1","key":"10.1016\/j.biopha.2026.119732_bib4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119732_bib5","first-page":"15","article-title":"Bile acids in inflammation and metabolism: from molecular mechanisms to clinical relevance","volume":"60","author":"Behrendt","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119732_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.dld.2013.10.021","article-title":"The bile acid TGR5 membrane receptor: from basic research to clinical application","volume":"46","author":"Duboc","year":"2014","journal-title":"Dig. Liver Dis."},{"issue":"10","key":"10.1016\/j.biopha.2026.119732_bib7","first-page":"4212","article-title":"TGR5 activation induces SHP and fibroblast growth factor 19 to inhibit bile acid synthesis in the liver","volume":"292","author":"Pathak","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119732_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2008.04.171","article-title":"Expression and function of the bile acid receptor TGR5 in Kupffer cells","volume":"372","author":"Keitel","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2026.119732_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.tips.2015.08.002","article-title":"TGR5 and immunometabolism: insights from physiology and pharmacology","volume":"36","author":"Perino","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119732_bib10","first-page":"683","article-title":"Bile acids and the gastrointestinal tract: the good, the bad, and the ugly","volume":"101","author":"Monteil","year":"2021","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2026.119732_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat. Med."},{"issue":"6013","key":"10.1016\/j.biopha.2026.119732_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.biopha.2026.119732_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.it.2015.03.006","article-title":"Re-examining the origin and function of liver-resident NK cells","volume":"36","author":"Peng","year":"2015","journal-title":"Trends Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119732_bib14","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.4049\/jimmunol.1601424","article-title":"Eomeshi NK cells in human liver are long-lived and do not recirculate but can be replenished from the circulation","volume":"197","author":"Cuff","year":"2016","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119732_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-065X.2006.00457.x","article-title":"Activation, coactivation, and costimulation of resting human natural killer cells","volume":"214","author":"Bryceson","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2026.119732_bib16","article-title":"Natural killer cells in idiopathic pulmonary fibrosis: protective or pathogenic?","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119732_bib17","article-title":"CX3CL1\/CX3CR1 axis regulates natural killer cell recruitment and activation in pulmonary fibrosis","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119732_bib18","first-page":"142","article-title":"FAK\/PXN signaling regulates NK cell activation in pulmonary fibrosis","volume":"20","author":"Liu","year":"2022","journal-title":"Cell. Commun. Signal."},{"issue":"11","key":"10.1016\/j.biopha.2026.119732_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119732_bib20","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: an update","volume":"196","author":"Michel","year":"2016","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119732_bib21","first-page":"3009","article-title":"Dysregulated NK cell activity contributes to acute lung injury","volume":"215","author":"Li","year":"2018","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.biopha.2026.119732_bib22","first-page":"322","article-title":"Acute lung injury and ARDS are mediated by NK cell activation through perforin-dependent cytotoxicity","volume":"64","author":"Smallwood","year":"2021","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119732_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","article-title":"Bile acids as metabolic regulators and nutrient sensors","volume":"39","author":"Chiang","year":"2019","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.biopha.2026.119732_bib24","article-title":"TGR5 signaling in cholestatic and metabolic liver disease: molecular insights and therapeutic perspectives","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119732_bib25","first-page":"L620","article-title":"Surfactant protein D as a biomarker for lung injury in murine models","volume":"298","author":"M\u00fcller","year":"2010","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119732_bib26","first-page":"2566","article-title":"Soluble receptor for advanced glycation end products (sRAGE) and acute lung injury","volume":"36","author":"Calfee","year":"2008","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.biopha.2026.119732_bib27","first-page":"1833","article-title":"Role of SP-D and sRAGE in predicting outcomes in acute lung injury","volume":"131","author":"Ware","year":"2007","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.biopha.2026.119732_bib28","first-page":"4971","article-title":"CD107a as a functional marker for NK cell cytotoxicity","volume":"105","author":"Bryceson","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.biopha.2026.119732_bib29","first-page":"4273","article-title":"NKp46: a key natural killer cell receptor","volume":"178","author":"Walzer","year":"2007","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119732_bib30","first-page":"914","article-title":"Diet-induced obesity impairs NK cell function in mice","volume":"34","author":"O\u2019Shea","year":"2010","journal-title":"Int. J. Obes."},{"issue":"7","key":"10.1016\/j.biopha.2026.119732_bib31","first-page":"L657","article-title":"Bile acids in bronchoalveolar lavage fluid: implications for lung injury","volume":"303","author":"Ding","year":"2012","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119732_bib32","first-page":"853","article-title":"Cytotoxic effects of bile acids on lung tissue: a review","volume":"194","author":"Upadhyay","year":"2016","journal-title":"Lung"},{"issue":"5","key":"10.1016\/j.biopha.2026.119732_bib33","first-page":"619","article-title":"TGR5 mediates profibrotic effects in pulmonary fibrosis","volume":"63","author":"Yan","year":"2020","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119732_bib34","first-page":"291","article-title":"Hepatopulmonary syndrome: pathophysiology and clinical presentation","volume":"47","author":"Fallon","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2026.119732_bib35","first-page":"1469","article-title":"Hepatopulmonary syndrome: prevalence and impact on survival","volume":"105","author":"Krowka","year":"1993","journal-title":"Gastroenterology"},{"issue":"7121","key":"10.1016\/j.biopha.2026.119732_bib36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119732_bib37","first-page":"629","article-title":"Adipose tissue inflammation and lung injury","volume":"6","author":"Wensveen","year":"2015","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119732_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in metabolic regulation and inflammation","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119732_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000324126","article-title":"The bile acid membrane receptor TGR5: a valuable metabolic target","volume":"29","author":"Pols","year":"2011","journal-title":"Dig. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2026.119732_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.dld.2013.10.021","article-title":"The bile acid TGR5 membrane receptor: from basic research to clinical application","volume":"46","author":"Duboc","year":"2014","journal-title":"Dig. Liver Dis."},{"issue":"10","key":"10.1016\/j.biopha.2026.119732_bib41","first-page":"4212","article-title":"TGR5 activation induces SHP and fibroblast growth factor 19 to inhibit bile acid synthesis in the liver","volume":"292","author":"Pathak","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119732_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:47:57Z","timestamp":1787179677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"alternative-id":["S0753332226007687"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119732","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TGR5 activation impairs lung natural killer cell function and promotes bile acid\u2013mediated injury in metabolic liver disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119732"}}